Saratov JOURNAL of Medical and Scientific Research
Home

Frequency of symptoms of viral conjunctivitis in patients with SARS-CoV-2 coronavirus infection

Year: 2021, volume 17 Issue: №2 Pages: 263-266
Heading: Тhematic supplement Article type: Original article
Authors: Azamatova G.A., Gaysina G.Ya., Khairullina A.I., Edeleva K.R., Yagafarova D.A.
Organization: Bashkir State Medical University of the Russian Health Care
Summary:

Purpose: to identify the frequency of symptoms of viral conjunctivitis in persons with a new coronavirus infection. Material and Methods. The data of a survey of 100 patients diagnosed with "bilateral pneumonia with laboratory-confirmed polymerase chain reaction (PCR) coronavirus infection (U07.1)" were analyzed. Results. The analysis of the survey results showed the presence of symptoms of viral conjunctivitis in 53% of the 100 patients surveyed. The most common symptom was eye pain (in 29 respondents, or 54.7% of patients with symptoms of conjunctivitis). Further in descending order: blurred vision (27 respondents), eye discomfort (23 respondents), lacrimation (23 respondents), itchy eyes (21 respondents), burning eyes (19 respondents), sore eyes in bright light (15 respondents), redness of the eyes (conjunctiva and eyelids) (12 respondents), discharge from the eyes (mucous, purulent) (11 respondents), edema of the conjunctiva and eyelids (7 respondents). Conclusion. Most patients with a confirmed diagnosis of coronavirus infection have symptoms of viral conjunctivitis (53% of patients). This fact indicates the need for mandatory diagnosis, timely treatment and prevention of viral conjunctivitis in patients with a confirmed diagnosis of coronavirus infection.

Keywords: coronavirus infection, SARS-CoV-2, viral conjunctivitis

Bibliography:
1. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). In: Temporary methodological guidelines. 11th ed. Moscow: Ministry of Health of the Russian Federation, 2021; p. 6-15.
2. COVID-19: Clinical management guidance. In: Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2th ed. Geneva: World Health Organization, 2021; p. 9-10.
3. Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird's Eye View. Int J Occup Environ Med 2020; 11: 65-71.
4. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
5. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocullmmunol Inflamm2020; 16: 1-5.
6. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565-74.
7. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395: 39.
8. Beeching NJ, Fletcher ТЕ, Fowler R. Best Practice Coronavirus disease 2019 (COVID-19). BMJ 2020; 3: 4-5.
9. Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. Published online March 31, 2020.

AttachmentSize
2021_02-1_263-266.pdf599.45 KB
All articles of the authors: Azamatova G.A. , Edeleva K.R., Gaysina G.Ya. , Khairullina A.I., Yagafarova D.A.

No votes yet